Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview

Marília Rocha Laurentino1, Sérgio Luiz Arruda Parente Filho2, Lívia Leal Chagas Parente3

  • 1Post-Graduation Program in Pharmaceutical Sciences, School of Pharmacy, Federal University of Ceara, Capitão Francisco Pedro, Street, n.1210 - Rodolfo Teófilo, Fortaleza, Ceara, CEP 60430-370, Brazil. marilialaurentino@gmail.com.

Annals of Hematology
|October 24, 2019
PubMed

Insights

Sickle cell disease (SCD) causes significant kidney damage, leading to end-stage renal disease (ESRD). New biomarkers like KIM-1, NGAL, and MCP-1 show promise for early detection of kidney injury in SCD patients.

Area of Science:

  • Hematology
  • Nephrology
  • Genetics

Background:

  • Sickle cell disease (SCD) is an inherited disorder caused by the hemoglobin S (HbS) gene.
  • SCD leads to severe complications including chronic hemolysis, endothelial damage, and vaso-occlusion, resulting in multi-organ damage.
  • Kidney impairment is a frequent complication of SCD, manifesting as urinary issues, glomerulopathies, proteinuria, hematuria, and often progressing to end-stage renal disease (ESRD).

Purpose of the Study:

  • To investigate novel biomarkers for early diagnosis of kidney damage in sickle cell disease.
  • To assess the potential of kidney injury molecule 1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and monocyte chemoattractant protein 1 (MCP-1) as indicators of renal impairment in SCD.

Main Methods:

  • The study focuses on evaluating the utility of specific novel biomarkers.
  • Methods involve assessing KIM-1, NGAL, and MCP-1 levels in patients with SCD.
  • These biomarkers are analyzed in relation to established indicators of renal function and damage.

Main Results:

  • Preliminary findings suggest that KIM-1, NGAL, and MCP-1 may serve as early indicators of renal injury in SCD.
  • These biomarkers could potentially detect kidney damage before significant functional decline or overt symptoms appear.
  • Further research is needed to validate these findings and establish clinical utility.

Conclusions:

  • Early detection of kidney damage in SCD is crucial for timely intervention and management.
  • Novel biomarkers such as KIM-1, NGAL, and MCP-1 hold promise for improving the diagnosis of renal complications in SCD.
  • Continued investigation into these biomarkers could lead to better patient outcomes and reduced progression to ESRD.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
236
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
331
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
1.0K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
389
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
497
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
174